Selection of Broad-Spectrum Cephalosporin-resistantEscherichia Coliin the Feces of Healthy Dogs After Administration of First-Generation Cephalosporins

Microbiology and Immunology - United States
doi 10.1111/1348-0421.12466
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pharmacokinetics of Cefonicid, a New Broad-Spectrum Cephalosporin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Absorption, Distribution and Excretion of SCE-963, a New Broad-Spectrum Cephalosporin, in Mice, Rats, Rabbits and Dogs.

Journal of Antibiotics
Drug DiscoveryPharmacology
1978English

Evaluation of the in Vitro Activity of BMY-28142, a New Broad-Spectrum Cephalosporin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Crossover Assessment of Serum Bactericidal Activity and Pharmacokinetics of Five Broad-Spectrum Cephalosporins in the Elderly.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

Third-Generation Cephalosporin-Resistant Non-Typhoidal Salmonella Isolated From Human Feces in Japan

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Shiga Toxigenic and Atypical EnteropathogenicEscherichia Coliin the Feces and Carcasses of Slaughtered Pigs

Foodborne Pathogens and Disease
Applied MicrobiologyMicrobiologyFood ScienceAnimal ScienceZoologyBiotechnology
2012English

Activities of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin, Against Haemophilus Influenzae and Moraxella Catarrhalis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

In Vitro and in Vivo Activities of DN-9550, a New Broad-Spectrum Cephalosporin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy